The 1969 Interim Meeting of the American Rheumatism Association.
D000974:Antibodies, Antinuclear; D001168:Arthritis / Q000209:etiology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003106:Colon / Q000601:surgery; D003520:Cyclophosphamide / Q000627:therapeutic use; D006073:Gout / Q000378:metabolism; D006801:Humans; D007421:Intestine, Small / Q000601:surgery; D008180:Lupus Erythematosus, Systemic; D011183:Postoperative Complications; D012216:Rheumatic Diseases; D012217:Rheumatoid Factor / Q000032:analysis; D012411:Rubella Vaccine / Q000009:adverse effects; D012412:Rubella virus; D012955:Societies, Medical; D014765:Viral Vaccines / Q000009:adverse effects; D005719:gamma-Globulins / Q000032:analysis
D000974:Antibodies, Antinuclear; D012411:Rubella Vaccine; D014765:Viral Vaccines; D005719:gamma-Globulins; D003520:Cyclophosphamide; D012217:Rheumatoid Factor